ANO1 and prostate carcinoma: In summary, ANO1 is overexpressed in highly metastatic PC3 cells, but shows minimal expression in low metastatic LNCap and DU145 prostate cancer cells, indicating its possible role in regulating metastatic potential in prostate cancer.